๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 22 Shanghai 21 Beijing 14 Wuhan 9 Hangzhou 7
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou22 Shanghai21 Beijing14 Wuhan9 Hangzhou7
All 31 locations
Target enrolment
to

Trials with a site in Beijing

14 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)
NCT07306390Colon Cancer, Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
1,200
Beijing
2026-07-01
Recruiting
SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT07209787Rectal Cancer
Beijing Chao Yang Hospital
Phase 4
966
Beijing
2025-10-21
Active, closed
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
NCT07711509Rectal Cancer, Low Anterior Resection Syndrome, Fecal Incontinence, Diversion Colitis
Peking University People's Hospital
Not applicable
35
Beijing
2025-03-25
Recruiting
Rectal Cancer Neoadjuvant Therapy-Real World Study
NCT07566559Rectal Cancer
Beijing Friendship Hospital
Observational
869
Beijing
2025-01-01
Not yet open
Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer
NCT06443671Rectal Cancer
DrugCapeox
Peking University Cancer Hospital & Institute
Phase 2/3
132
Beijing
2024-06-01
Recruiting
Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer
NCT06209099Rectal Cancer
Peking University Cancer Hospital & Institute
Not applicable
96
Beijing
2024-01-17
Recruiting
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
NCT06146946Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
1,384
Beijing, Shanghai, Chengdu
2023-12-01
Recruiting
Reasons for Non-reversal of Temporary Stomas After Surgeries of Mid-low Rectal Cancer ๏ผˆNORESTO Study๏ผ‰
NCT06194708Rectal Cancer
Peking Union Medical College Hospital
Observational
235
Beijing
2023-05-15
Recruiting
Total Neoadjuvant Treatment ยฑImmunotherapy for High Risk Locally Advanced Rectal Cancer (TNTi)
NCT06229041Rectal Cancer
Peking University Cancer Hospital & Institute
Phase 3
472
Beijing
2023-03-29
Recruiting
Chinese Colorectal Cancer Database
NCT05434026Colonic Cancer, Rectal Cancer, Prospective Studies
Beijing Friendship Hospital
Observational
200,000
Beijing
2022-08-03
Active, closed
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer
NCT05009069Rectal Neoplasms, Rectal Cancer
Hoffmann-La Roche
Phase 2
58
Beijing, Guangzhou, Hangzhou, Shanghai, Shenyang
2022-03-18
Recruiting
Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy of Colorectal Cancer
NCT05424692Colon Cancer, Rectal Cancer, Chemotherapy Effect, PTC
Peking Union Medical College Hospital
Not applicable
200
Beijing
2021-09-01
Recruiting
Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer
NCT04743102Rectal Cancer, Neoadjuvant Therapy, Complete Remission, Metastasis
Beijing Chao Yang Hospital
Not applicable
260
Beijing
2021-01-01
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

10 of the 14 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 14 studies
PhaseStudiesRecruitingShare
Not applicable5435.7%
Observational4328.6%
Phase 22114.3%
Phase 2/3107.1%
Phase 3117.1%
Phase 4117.1%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Peking Union Medical College Hospital33
Peking University Cancer Hospital & Institute32
Beijing Chao Yang Hospital22
Beijing Friendship Hospital22
Cancer Institute and Hospital, Chinese Academy of Medical Sciences21
Hoffmann-La Roche10
Peking University People's Hospital10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.